Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity

Ganiou Assani; Yudi Xiong; Fuxiang Zhou; Yunfeng Zhou

doi:10.18632/oncotarget.26150

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity

Ganiou Assani, Yudi Xiong, Fuxiang Zhou and Yunfeng Zhou _

PDF | HTML | How to cite

Oncotarget. 2018; 9:35008-35025. https://doi.org/10.18632/oncotarget.26150

Metrics: PDF 1636 views | HTML 3283 views | ?

Abstract

Ganiou Assani1,2,3, Yudi Xiong1,2,3, Fuxiang Zhou1,2,3 and Yunfeng Zhou1,2,3

1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China

2Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China

3Hubei Key Laboratory of Tumor Biology Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, China

Correspondence to:

Yunfeng Zhou, email: [email protected]

Keywords: cancer cells; telomere; telomerase; radiosensitivity; radiotherapy

Received: May 29, 2018 Accepted: July 31, 2018 Published: October 09, 2018

ABSTRACT

Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the limitation of cancer radiotherapy effectiveness in the cancer patients. Moreover, reduction of the limitation of cancer radiotherapy effectiveness by reducing the side effects post-cancer radiotherapy and cancer radioresistance is the aim of several radiotherapy-oncologic teams. Otherwise, Telomere and telomerase are two cells components which play an important role in cancer initiation, cancer progression and cancer therapy resistance such as radiotherapy resistance. For resolving the problems of the limitation of cancer radiotherapy effectiveness especially the cancer radio-resistance problems, the radio-gene-therapy strategy which is the use of gene-therapy via modulation of gene expression combined with radiotherapy was developed and used as a new strategy to treat the patients with cancer. In this review, we summarized the information concerning the implication of telomere and telomerase modulation in cancer radiosensitivity.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26150

Publication Alerts

Reviews:

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity

Abstract